DALLAS--(BUSINESS WIRE)--Kendall Law Group, led by former federal judge Joe Kendall, is investigating certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on behalf of shareholders to determine whether the officials breached their fiduciary duties to shareholders. Regeneron Pharmaceuticals develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. If you currently own shares of Regeneron and want to know more about